We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

34 hedge funds and large institutions have $3.81M invested in Vaxart in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0% more funds holding

Funds holding: 34 → 34 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.7% less ownership

Funds ownership: 2.28% → 1.58% (-0.7%)

43% less capital invested

Capital invested by funds: $6.64M → $3.81M (-$2.83M)

Holders
34
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$96.2K
2
PAM
Panagora Asset Management
Massachusetts
+$19.6K
3
Citadel Advisors
Citadel Advisors
Florida
+$18.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17.2K
5
JP Morgan Chase
JP Morgan Chase
New York
+$15.2K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$944K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$672K
3
BCM
Bridgeway Capital Management
Texas
-$140K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$131K
5
Deutsche Bank
Deutsche Bank
Germany
-$92.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAM
1
Krensavage Asset Management
New York
$1.59M -$17K -2,436 -0.9%
Renaissance Technologies
2
Renaissance Technologies
New York
$762K +$96.2K +13,765 +13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$453K -$131K -18,713 -20%
BlackRock
4
BlackRock
New York
$275K +$748 +107 +0.2%
GCIA
5
Gabelli & Co Investment Advisers
New York
$127K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$94K – – –
CCM
7
Carlson Capital Management
Minnesota
$89K – – –
WT
8
Wellcome Trust
United Kingdom
$72K – – –
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$56K – – –
GF
10
Gabelli Funds
New York
$36K – – –
Northern Trust
11
Northern Trust
Illinois
$36K +$1.14K +163 +3%
Citadel Advisors
12
Citadel Advisors
Florida
$30K +$18.3K +2,616 +121%
TL
13
TowerView LLC
New York
$20K -$88.9K -12,727 -80%
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$20K – – –
VF
15
Virtu Financial
New York
$19K -$38K -5,443 -64%
PAM
16
Panagora Asset Management
Massachusetts
$17K +$19.6K +2,809 New
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$15K +$17.2K +2,458 New
WS
18
Wedbush Securities
California
$14K +$6.74K +964 +75%
JP Morgan Chase
19
JP Morgan Chase
New York
$14K +$15.2K +2,170 New
State Street
20
State Street
Massachusetts
$13K – – –
UBS Group
21
UBS Group
Switzerland
$12K +$13.1K +1,880 +23,500%
GC
22
Guggenheim Capital
Illinois
$10K -$1.43K -204 -11%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$9K +$1.08K +154 +12%
RJFSA
24
Raymond James Financial Services Advisors
Florida
$9K +$1.27K +182 +14%
TSS
25
Two Sigma Securities
New York
$8K +$9K +1,288 New
1
2

VXRT Hedge Fund Activity: Q4 2017 in Review

34 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2017, worth a combined $3.81M — down 43% from $6.64M a quarter earlier.

Fund positioning in VXRT was balanced in Q4 2017: 5 funds opened new positions, 5 closed out, 9 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $96.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $944K sold.

  • 34 institutional investors held Vaxart (VXRT) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $3.81M of Vaxart stock for Q4 2017, down 43% quarter-over-quarter.
  • 5 funds opened new Vaxart positions in Q4 2017 and 5 closed out, a net change of 0 holders.
  • The largest Vaxart buyer in Q4 2017 was Renaissance Technologies, an estimated $96.2K added.
  • The largest Vaxart seller in Q4 2017 was Armistice Capital, an estimated $944K sold.

Based on aggregated 13F filings for Q4 2017.